Cell-Based Immunotherapy With Mesenchymal Stem Cells Cures Bisphosphonate-Related Osteonecrosis of the Jaw–like Disease in Mice
Patients on high-dose bisphosphonate and immunosuppressive therapy have an increased risk of bisphosphonate-related osteonecrosis of the jaw (BRONJ); despite the disease severity, its pathophysiology remains unknown, and appropriate therapy is not established. Here we have developed a mouse model of...
Main Authors: | Kikuiri, Takashi, Kim, Insoo, Yamaza, Takyoshi, Akiyama, Kentaro, Zhang, Qunzhou, Li, Yunsheng, Chen, Chider, Chen, WanJun, Wang, Songlin, Le, Anh D, Shi, Songtao |
---|---|
Format: | Online |
Language: | English |
Published: |
Wiley Subscription Services, Inc., A Wiley Company
2010
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154005/ |
Similar Items
-
Osteonecrosis of jaw associated with bisphosphonate use
by: Rastogi, Ashu, et al.
Published: (2012) -
Bisphosphonate-related osteonecrosis of the jaws (Bronj)
by: Beninati, Francesco, et al.
Published: (2013) -
Osteonecrosis of the jaws in patients treated with bisphosphonates
by: Ata-Ali, Fadi, et al.
Published: (2012) -
Bisphosphonate-Related Osteonecrosis of the Jaw: Specificities
by: Paulo, Siri, et al.
Published: (2014) -
Osteoporosis and Bisphosphonate-Related Osteonecrosis of the Jaw Bone
by: Villa, Alessandro, et al.
Published: (2011)